Participate in an imaging revolution.
iThera Medical offers the next generation in molecular imaging. Introducing MSOT - Multispectral Optoacoustic Tomography.
With its unique ability to accurately visualize and quantify tissue molecules, nanoparticles, biomarkers and optical agents, in vivo and in real time, through several centimeters of tissue, MSOT stands at the forefront of the next era in biomedical imaging.
MSOT Clinical Translation
Based on the real-time multispectral imaging technology proven in iThera Medical’s MSOT inSight / inVision small animal imaging systems, a handheld MSOT imaging system for translational and clinical research use, the MSOT Acuity, is now available (not yet approved as a medical device by FDA or CE).
For more information: click here or play video.
MSOT Small Animal Imaging
iThera Medical offers a range of small animal scanners with varying hardware and software configurations. All systems enable whole-body deep-tissue imaging in real time.
For more information: click here.
Hybrid OA / US Technology
iThera Medical recently launched an integrated OPtoacoustic / UltraSound (OPUS) imaging technology. The MSOT inVision 512-echo is the world's first hybrid tomographic OPUS imaging system, providing unparalelled and user-independent image quality, in real time, throughout the entire animal cross-section.
For more information: click here.
Application Highlight: DCE-MSOT
MSOT has the capability to capture fast processes in vivo with high spatiotemporal resolution. Per-pixel analysis allows fitting of a pharmacokinetic model and calculation of parametric maps. Related applications include perfusion and probe targeting / clearance studies: see poster
xPLORE Probes
iThera Medical markets a proprietary line of probes optimized for the use with MSOT. The initial portfolio of three xPLORE© probes consists of two targeted reagents for the use in disease models related to cancer and inflammation as well as one blood pool agent with long circulation time.
For more information: click here.
- Attia ABE et al.,.
Noninvasive real-time characterization of non-melanoma skin cancers with handheld optoacoustic probes,
Photoacoustics. 2017 Sep; 7: 20–26. DOI: 10.1016/j.pacs.2017.05.003.
Link - Tang J et al.,.
Dual-mode Imaging-Guided Synergistic Chemo- and Magnetohyperthermia Therapy in a Versatile Nanoplatform to Eliminate Cancer Stem Cells,
ACS Appl. Mater. Interfaces. DOI: 10.1021/acsami.7b06393.
Link - Du J et al.,.
Design of TPGS-functionalized Cu3BiS3 nanocrystals with strong absorption in the second near-infrared window for radiation therapy enhancement,
Nanoscale. 2017 Jun 22;9(24):8229-8239. DOI: 10.1039/c7nr02213a.
Link - Shi Y et al.,.
The interactions of single-wall carbon nanohorns with polar epithelium,
Int J Nanomedicine. 2017 Jun 1;12:4177-4194. DOI: 10.2147/IJN.S133295.
Link - Berninger MT et al.,
Detection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomography,
Photoacoustics. 2017 Jun; 6: 37–47. DOI: 10.1016/j.pacs.2017.04.002
Link - Jiang X et al.,
Ultra-Small Magnetic CuFeSe2 Ternary Nanocrystals for Multimodal Imaging Guided Photothermal Therapy of Cancer,
ACS Nano. 2017 May 19. DOI: 10.1021/acsnano.7b01032.
Link - Bao S et al.,
Gold nanocages with dual modality for image-guided therapeutics,
Nanoscale. 2017 May 19. DOI: 10.1039/c7nr01350g.
Link - Mercep E et al.,
Combined Pulse-Echo Ultrasound and Multispectral Optoacoustic Tomography with a Multi-Segment Detector Array,
IEEE Trans Med Imaging. 2017 May 18. DOI: 10.1109/TMI.2017.2706200.
Link - Ni Y et al.,
Push-pull type meso-ester substituted BODIPY near-infrared dyes as contrast agents for photoacoustic imaging,
Org Biomol Chem. 2017 May 17. DOI: 10.1039/c7ob00965h.
Link - Aguirre J et al.,
Precision assessment of label-free psoriasis biomarkers with ultra-broadband optoacoustic mesoscopy,
Nat. Biomed. Eng. 1, 0068 (2017). DOI:10.1038/s41551-017-0068.
Link